News for hackers. Stuff that matters.
Re:Moderna will develop mRNA vaccines for some of the world’... by refurb on Saturday March 12, 2022 @12:40AM (#30649238)
Yes but the problem with dengue is antibody mediated enhancement.

Basically people develop antibodies that make future infections worse by potential infections the infectious proteins.

The challenge is not creating a vaccine that stimulates an immune response, the challenge is avoiding a response that makes things worse.

Re:Moderna will develop mRNA vaccines for some of the world’... by jcims on Saturday March 12, 2022 @01:07AM (#30649337)
No idea really but maybe there are specific proteins in the virus that are responsible for this behavior that could be omitted from the vaccine while still finding an effective surface feature to work against?

> The challenge is not creating a vaccine that stimulates an immune response, the challenge is avoiding a response that makes things worse.

Agreed. This is probably always true, there’s just more concrete evidence of this potential outcome with dengue.

Re:Moderna will develop mRNA vaccines for some of the world’... by mise_en_place on Saturday March 12, 2022 @02:32AM (#30649691)
If you never had dengue before, wouldn’t you always have the same response due to vaccine mediated original antigenic sin?
Re:Moderna will develop mRNA vaccines for some of the world’... by refurb on Saturday March 12, 2022 @03:49AM (#30650029)
It’s been a while since my immunology courses, but I’ll give it a go.

Antibody response is not necessarily the same, even in the same person with the same antigen.

The immune system basically creates a ton of random antibodies and when they “hit” on the previously unseen antigen, they are amplified.

Now once someone has had an immune response and generated memory cells, then yes, very similar antigens (that somewhat bind to the exist ones the body made prior) will tend to “narrow down” the antibodies generated to varieties of the original one (the immune system basically says ‘these old antibodies are close, so let’s create variation off them to optimize the new ones’).

Then the other thing to consider is that there are different strains of dengue - so you could get type A, generate a response, but then exposed to type B where your type A antibodies activate the infection mechanism rather than disable it.